The purpose of this study is to demonstrate the efficacy of GSK Biologicals' influenza vaccine (Fluarix™) administered intramuscularly in adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
7,632
GSK Investigational Site
Hradec Králové, Czechia
GSK Investigational Site
Espoo, Finland
GSK Investigational Site
Helsinki, Finland
occurrence of confirmed influenza
occurrence of influenza like illness
Occurrence of pneumonia
Immune response at days 0 and 21
Safety during 7 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Helsinki, Finland
GSK Investigational Site
Jarvenpaa, Finland
GSK Investigational Site
Kotka, Finland
GSK Investigational Site
Kuopio, Finland
GSK Investigational Site
Lahti, Finland
GSK Investigational Site
Oulu, Finland
GSK Investigational Site
Pori, Finland
...and 5 more locations